Amanote Research
Register
Sign In
Letter: Would Aspirin Alleviate Fibrosis in Alcoholic Liver Disease?
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/apt.13655
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
June 13, 2016
Authors
Y. Lu
Publisher
Wiley
Related search
Modern Approaches to Fibrosis Diagnostics in Alcoholic Liver Disease
Doctor.Ru
Letter: Use of Collagen Proportionate Area to Quantify Liver Fibrosis and Predict Clinical Outcomes in Non-Alcoholic Fatty Liver Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Ethyl Pyruvate Can Alleviate Alcoholic Liver Disease Through Inhibiting Nrf2 Signaling Pathway
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Non-Invasive Diagnosis of Fibrosis in Non-Alcoholic Fatty Liver Disease
Journal of Clinical and Experimental Hepatology
Hepatology
Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
PLoS ONE
Multidisciplinary
Current Modalities of Fibrosis Assessment in Non-Alcoholic Fatty Liver Disease
Journal of Clinical and Translational Hepatology
Letter: Use of Collagen Proportionate Area to Quantify Liver Fibrosis and Predict Clinical Outcomes Non-Alcoholic Fatty Liver Disease-Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
PLoS ONE
Multidisciplinary
Sarcopenia Is Associated With Severe Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology